NIEHS SBIR Phase IIB Awards for Validation and Commercialization of Approaches
to Reduce Animal Use in Toxicology Testing (U44)
This FOA provides additional support to SBIR/STTR Phase II grantees for the
validation and commercialization of methods that either replace or reduce the
number of animals (referred to as alternative test methods) used in in vivo
toxicology screening and testing requirements set forth by US federal
government agencies.
Proposed projects must address non-clinical toxicology testing requirements
currently used or required by a US federal government agency. Applicants must
submit a Validation and Commercialization Plan, which should include details on
a specific US federal agency's required endpoint(s) being assessed and a
description of anticipated impact on the 3Rs of animal use (reduction,
refinement and/or replacement) with adoption and implementation of the
alternative test method. A listing of the different agency regulations and
guidelines, by topic, can be found on the NTP website at
http://ntp.niehs.nih.gov/pubhealth/evalatm/regs-guidelines/.
- See more at:
http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-15-016.html#sthash.hhTkRkak.dpuf
General info at: http://grants.nih.gov/grants/guide/rfa-files/RFA-ES-15-016.html
With best regards,
Jan van der Valk
Jan van der Valk, PhD | 3Rs-Centre Utrecht Life Sciences | Dept. Animals in
Science and Society | Fac. Veterinary Medicine | Utrecht University | Yalelaan
2 | NL-3584 CM Utrecht | The Netherlands | Email:
j.vandervalk@xxxxx<mailto:j.vandervalk@xxxxx> | Ph. *31 30 253 2163 / 2186 |
Fax.*31 30 253 7997 | URL: http://www.uu.nl/3RsCentreULS | Twitter:
@3VCentrumULS |
